Clinical Trials

Sponsor: Wake Forest University

Sponsor Study ID: WF2304-A172401

Study Title: Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

CTO #: 104209

NCT Number: NCT06418204

Phase: N/A

Protocol Type: Other

Age Group: Adults

Disease Sites: Breast; Colon; Melanoma, Skin; Non-Hodgkin's Lymphoma; Rectum

Study Objectives: To examine the association between cannabis and/ or cannabinoid use and cancer related symptoms associated monthly for one year in adults newly diagnosed with breast, colorectal, melanoma, non-hodgkin lymphoma, or non-small cell lung cancer who are planning or recently started to receive one or more systemic cancer directed therapies with chemotherapy and/or immune check point inhibitors targeting PD-1, PDL1 or CTLA-4.



Study Documents          eConsent: No
(MUSC NetID required for document access)